Last reviewed · How we verify
Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical Study
The purpose of this study is to evaluate the clinical safety and efficacy of QingReMoShen Granule to treat idiopathic membranous nephropathy.
Details
| Lead sponsor | wanglin |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 72 |
| Start date | 2011-11 |
| Completion | 2016-09 |
Conditions
- Idiopathic Membranous Nephropathy
Interventions
- Losartan Tablets & QingReMoShen Granule
- Losartan Tablets & Placebo Granule
Primary outcomes
- 24-hour urine protein — At the 24thweek
Countries
China